Cargando…

Stereotactic Radiotherapy for Oligometastases in Lymph Nodes—A Review

In recent years, the concept of oligometastases has become accepted and reports on stereotactic body radiotherapy as a treatment method have been published. Lesions in the brain, lung, and liver have been reported as target lesions. However, lymph node oligometastases could be a good candidate for s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsushita, Haruo, Jingu, Keiichi, Umezawa, Rei, Yamamoto, Takaya, Ishikawa, Yojiro, Takahashi, Noriyoshi, Katagiri, Yu, Kadoya, Noriyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201169/ https://www.ncbi.nlm.nih.gov/pubmed/30352542 http://dx.doi.org/10.1177/1533033818803597

Ejemplares similares

Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Jingu, Keiichi, et al.
Publicado: (2018)

Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer
por: Yamamoto, Takaya, et al.
Publicado: (2018)

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016)

Stereotactic body radiotherapy for kidney cancer: a 10-year experience from a single institute
por: Yamamoto, Takaya, et al.
Publicado: (2021)

Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy
por: Yamamoto, Takaya, et al.
Publicado: (2015)

Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer
por: Takeda, Kazuya, et al.
Publicado: (2021)

Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy
por: Tasaka, Shun, et al.
Publicado: (2021)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors
por: Yamamoto, Takaya, et al.
Publicado: (2014)

Cardiac impacts of postoperative radiotherapy for breast cancer in Japanese patients
por: Segawa, Erika, et al.
Publicado: (2023)

Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
por: Yamamoto, Takaya, et al.
Publicado: (2022)

Differential abscopal effect in extracranial and intracranial lesions after radiotherapy alone for vertebral bone metastasis of unknown primary: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocols-
por: Umezawa, Rei, et al.
Publicado: (2015)

Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study
por: Takahashi, Noriyoshi, et al.
Publicado: (2016)

Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study
por: Yamamoto, Takaya, et al.
Publicado: (2022)

Palliative radiotherapy for gastric cancer bleeding: a multi-institutional retrospective study
por: Takeda, Kazuya, et al.
Publicado: (2022)

Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging Study
por: Umezawa, Rei, et al.
Publicado: (2020)

Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy
por: Kozumi, Maiko, et al.
Publicado: (2018)

Clinical experience of pelvic radiotherapy or chemoradiotherapy for postoperative uterine cervical cancer using intensity-modulated radiation therapy
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Longitudinal analyses and predictive factors of radiation-induced lung toxicity-related parameters after stereotactic radiotherapy for lung cancer
por: Yamamoto, Takaya, et al.
Publicado: (2022)

Successful treatment with radiation therapy for desmoid-type fibromatosis with unilateral hydronephrosis: a case report
por: Ishikawa, Yojiro, et al.
Publicado: (2021)

Radiation recall phenomenon after administration of the mRNA-1273 SARS-CoV-2 vaccine
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Assessment of myocardial metabolic disorder associated with mediastinal radiotherapy for esophageal cancer -a pilot study-
por: Umezawa, Rei, et al.
Publicado: (2015)

Evaluation of DIBH and VMAT in Hypofractionated Radiotherapy for Left-Sided Breast Cancers After Breast-Conserving Surgery: A Planning Study
por: Tang, Liuwei, et al.
Publicado: (2021)

Comparison of acute gastrointestinal toxicities between 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy including prophylactic regions in chemoradiotherapy with S-1 for pancreatic cancer—importance of dose volume histogram parameters in the stomach as the predictive factors-
por: Umezawa, Rei, et al.
Publicado: (2022)

Clinical impact of radiation-induced myocardial damage detected by cardiac magnetic resonance imaging and dose-volume histogram parameters of the left ventricle as prognostic factors of cardiac events after chemoradiotherapy for esophageal cancer
por: Umezawa, Rei, et al.
Publicado: (2023)

Long-Term Survival Following Palliative Chemoradiotherapy in an Elderly Patient With Advanced Squamous Cell Carcinoma in the Right Mandibular Gingiva
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
por: Yamamoto, Takaya, et al.
Publicado: (2020)

Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis
por: Shirata, Yuko, et al.
Publicado: (2012)

Brachytherapy for primary nasal vestibule cancer using Au-198 grains
por: Harada, Hinako, et al.
Publicado: (2022)

Pre-treatment Evaluation of Patients Eligible for Whole Brain Radiation Therapy: The Risk of Hippocampal Metastases in a Retrospective Study of 248 Cases at a Single Institution
por: Ishikawa, Yojiro, et al.
Publicado: (2023)

Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes
por: Wang, Huan-Huan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kkjjb56eu8euetvppa80ub6aqc